Please login to the form below

Not currently logged in
Email:
Password:

Mundipharma appoints Dr Alberto Martinez as president and CEO

He succeeds Antony Mattessich, who leaves after 12 years with the networked company

Alberto MartinezMundipharma has appointed Dr Alberto Martinez as its new president and chief executive officer, succeeding Antony Mattessich, who leaves the network after 12 years of service to pursue his career in the US.

Dr Martinez’ career has seen him gain expertise in the healthcare and pharmaceutical fields, more specifically in the strategic, financial and operational capacity.

His new role will see him take responsibility for strengthening Mundipharma’s network in Europe and focus on its alliances.

Additionally, research and development, global manufacturing, supply chain and IT functions will fall under Dr Martinez’s new remit.

He said: “I feel honoured and privileged to be given the opportunity to lead the Mundipharma organisations in Europe in the next chapter of our evolution and success. I am committed to ensure that we remain ambitious and agile so we continue to bring valuable and innovative medicines to patients and healthcare providers as a successful, diversified and forward-thinking organisation.”

Dr Martinez originally joined the Mundipharma network in 2003 and has held roles of increasing responsibility over the past 14 years.

Prior to his time at Mundipharma, he served Napp Pharmaceuticals and Janssen in various capacities.

8th January 2018

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics